C. Dorrier

Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy.

R. Lees, P. Kozlovskis, P. Comp, 1995, Atherosclerosis.

Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal.

P. Kozlovskis, S. M. Gibson, P. Comp, 1993, The American journal of cardiology.

Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled t

P. Tugwell, C. Bombardier, V. Strand, 2000, Arthritis and rheumatism.

Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.

H. Paulus, D. Elashoff, D. Furst, 2005, Arthritis and rheumatism.

Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.

P. Tugwell, P. Tugwell, C. Bombardier, 1999, Arthritis and rheumatism.

Interim report on clinic intake and safety data collected from 17 NIDA-funded naltrexone studies.

A. Bradford, C. Dorrier, F. Hurley, 1976, NIDA research monograph.